1. Home
  2. BIRD vs EVAX Comparison

BIRD vs EVAX Comparison

Compare BIRD & EVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Allbirds Inc.

BIRD

Allbirds Inc.

HOLD

Current Price

$1.06

Market Cap

30.1M

ML Signal

HOLD

Logo Evaxion Biotech

EVAX

Evaxion Biotech

SELL

Current Price

$2.26

Market Cap

25.5M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
BIRD
EVAX
Founded
2015
2008
Country
United States
Denmark
Employees
N/A
N/A
Industry
Apparel
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
30.1M
25.5M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
BIRD
EVAX
Price
$1.06
$2.26
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
★ $12.25
AVG Volume (30 Days)
★ 382.6K
75.0K
Earning Date
11-13-2026
11-19-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 20.22
N/A
EPS
N/A
★ N/A
Revenue
★ $152,466,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$487.91
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$1.12
$2.03
52 Week High
$24.31
$6.92

Technical Indicators

Market Signals
Indicator
BIRD
EVAX
Relative Strength Index (RSI) 29.74 36.10
Support Level N/A N/A
Resistance Level $1.46 $4.56
Average True Range (ATR) 0.17 0.28
MACD -0.00 -0.07
Stochastic Oscillator 3.91 22.88

Price Performance

Historical Comparison
BIRD
EVAX

About BIRD Allbirds Inc.

Smartbird Inc delivers dedicated AI infrastructure as a service, giving organizations the performance, control, and security of a private AI cluster without requiring them to finance, operate, or maintain the underlying infrastructure. Smartbird manages the entire lifecycle, from procurement and deployment to operations and hardware refreshes, so customers can focus on AI workloads, not AI infrastructure.

About EVAX Evaxion Biotech

Evaxion AS is a clinical-stage TechBio company developing novel vaccines with its proprietary, clinically validated and scalable AI platform, AI-Immunology. The platform harnesses the power of artificial intelligence to decode the human immune system and develop novel vaccine candidates for cancer and infectious diseases for patients in the market. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing inventive and targeted treatment options.

Share on Social Networks: